CLOSE
Friday, April 26, 2024
Breast Cancer

by -
0 710

Colorectal cancer is the second most common cause of cancer-related death in the United States.

The incidence of EO-CRC, which refers to when people under 50 years of age develop the condition, has increased markedly in several wealthy countries.

One 2020 article in CA: A Cancer Journal for Clinicians suggested that over the course of the year, about 150,000 U.S. individuals would receive a diagnosis of colorectal cancer and about 53,200 would die as a result.

The authors also predicted about 18,000 cases of individuals younger than 50 years of age receiving a diagnosis of colorectal cancer, with 3,640 forecasted deaths in this population.

Compared with adults born in the U.S. around 1950, those born around 1990 have twice the risk of developing colon cancer and four times the risk of developing rectal cancer.

A new study in the journal Gut links drinking two or more SSBs per day in adulthood with a doubling in the risk of bowel cancer before the age of 50 years.

Researchers found that each daily SSB serving among adult women may be associated with a 16% higher risk of developing EO-CRC.

Also, the study found that each additional SSB serving per day among individuals aged 13–18 years may be linked to a 32% increase in the risk of developing EO-CRC.

Examples of SSBs include soft drinks, pre-packaged fruit drinks, energy drinks, and sports drinks. Sugary drinks are the leading source of added sugars in the American diet.

In fact, from 1977 to 2001, energy intake from SSBs increased by a whopping 135%.

Unique epidemiologic evidence

For this study, the researchers used data from 95,464 participants in the Nurses’ Health Study II. This is an ongoing monitoring study of 116,430 U.S. registered nurses, all women, who were aged 25–42 years when they enrolled in 1989.

Every 4 years beginning in 1991, the women in the study reported on what they ate and drank using validated food frequency questionnaires.

In 1998, researchers asked the participants to recall their health status and lifestyle habits as teenagers.

Also, 41,272 of the women reported on what they typically ate and drank as well as on the quantities of these items between 1960 and 1982. They were aged 13–18 years at this point.

The participants also gave information on potentially influential factors, including their family history of bowel cancer, their lifestyle habits, and any regular use of aspirin, nonsteroidal anti-inflammatory drugs, or vitamin supplements.

Over 24 years of monitoring, 109 women developed bowel cancer before the age of 50 years.

The study authors write that their findings “add unique epidemiologic evidence that SSB intake may partly contribute to the rapid increase of CRC in younger adults.”

Notes on the study

It is important for researchers to understand what is behind this increase, said study co-author Dr. Jeffrey Meyerhardt. He is the clinical director of the Gastrointestinal Cancer Center at the Dana-Farber Cancer Institute in Boston, MA.

“It is presumed that exposures early in life are contributing to this rise,” Dr. Meyerhardt told Medical News Today. “Studying exposures that can be prevented is [essential] to getting control of this rising health issue.”

Substituting SSBs with reduced-fat milk or whole milk appears to be beneficial, according to study co-author Dr. Yin Cao. She is an associate professor of surgery at the Washington University School of Medicine in St. Louis, MO.

“In this study,” she told us, “we showed [that] replacing one daily serving (8 oz) of SSBs with an equivalent amount of reduced-fat milk or total milk was associated with a 35–36% lower risk of EO-CRC.”

“During the second half of the 20th century, for which average U.S. per capita soft drink consumption has dramatically increased by ~500%, milk consumption has declined by half. Milk is a good source of calcium, a mineral found to be protective of colorectal cancer.”

“We postulate [that] low milk consumption could be plausibly linked with the increased risk of EO-CRC, and further research on this topic is in the pipeline.”

The researchers point to several limitations of their study. First, they caution that this was an observational study, which can only establish correlation, not cause. They also note that the majority of the participants were white women, so the findings may not apply to men or other ethnic groups.

Even so, the study provides insight into possible actions that public health leaders might take, Dr. Cao explained.

“Particularly in adolescence,” she wrote, “the immature and rapidly growing organs could be more susceptible to exposures that could lead to cancer development.”

“Campaigns, education programs, and interventions targeting the young population to reduce SSB intake and/or replace SSBs with other healthier beverages could help reduce the accrual of time at risk and convert this window of increased susceptibility into an opportunity for better health outcomes later in life.”

by -
0 710

Kidney cancer is the eighth most common cancer in adults, with just over 10,100 people diagnosed each year.

Signs and symptoms of kidney cancer can include: blood in your urine; a constant pain in your side, just below the ribs; and a lump or swelling in the kidney area (on either side of the body).

See your General Practitioner (GP) as soon as possible if you experience any of these symptoms. They will examine you and may refer you to a specialist clinic for further tests.

In around half of all cases of kidney cancer, there are no symptoms, and the condition is detected during tests for other unrelated conditions.

The kidneys and cancer
The kidneys are two bean-shaped organs located on either side of the body, just underneath the ribcage. Their main role is to filter out waste products from the blood, in addition to producing urine. Only one of the kidneys is usually affected by cancer.

The human body is made up of billions of cells, which normally grow and multiply in an orderly way, with new cells being created only when and where they’re needed. In cancer, this orderly process goes wrong and cells begin to grow and multiply uncontrollably.

Exactly what triggers this growth is unknown; however, there are certain risk factors that can increase the chances of the condition developing, such as smoking and obesity.

Kidney cancer most frequently affects people over 50 years of age and is more common among men.
Treating kidney cancer

The earlier kidney cancer is diagnosed, the easier it is to treat. How it is treated will depend on the size and spread of the cancer. Surgery to remove the cancerous cells is usually the first course of action.

Unlike most other cancers, chemotherapy isn’t very effective at treating kidney cancer. However, non-surgical treatments are available, such as radiotherapy or targeted therapies. These are most commonly used in the more advanced stages of kidney cancer, when the cancer has spread beyond the kidney.

Preventing kidney cancer
As the causes of kidney cancer aren’t fully understood, it is not possible to fully prevent it.

However, leading a healthy lifestyle may reduce the chances of developing the condition. A combination of a healthy diet and regular exercise will help to avoid becoming overweight or obese, which is a significant risk factor for kidney cancer.

If you are overweight or obese, you can lose weight and maintain a healthy weight by combining regular exercise with a calorie-controlled diet.

by -
0 699

According to the World Health Organization (WHO), cancer accounted for 10 million deaths worldwide in 2020. Globally, it is a leading cause of death.

In the United States, an estimated 39.5% of people will receive a cancer diagnosis within their lifetime.

Myths tend to develop around particularly prevalent conditions. It is no surprise, therefore, that people often misunderstand cancer.

“Cancer” is a generic term for a group of diseases that can affect any part of the body. This variety adds fuel to the fire of confusion.

In this article, we hope to dispel some myths and clarify this common and varied group of diseases.

1. Cancer is a death sentence

Cancer is not a death sentence. Despite the sobering statistics quoted above, cancer is not always terminal.

As scientists understand cancer better and develop improved treatments, recovery rates continue to improve.

For instance, in January 2019, an estimated 16.9 million cancer survivors were living in the United States. In the United Kingdom, survival rates have doubled in the last 40 years.

It is also worth noting that survival rates vary significantly depending on the type of cancer. For instance, in the U.K., survival rates for testicular cancer are 98%, whereas survival rates for pancreatic cancer are just 1%.

According to the National Cancer Institute:

“In the United States, the likelihood of dying from cancer has dropped steadily since the 1990s. Now, 5-year survival rates for some cancers, such as breast, prostate, and thyroid cancers, are 90% or better. The 5-year survival rate for all cancers combined is currently about 67%.”

Overall, cancer death rates are slowly declining, although the survival rates of some cancers are increasing more than others. An annual report on the status of cancer in the U.S., which appears in Cancer in 2020, concludes:

“[C]ancer death rates decreased 1.5% on average per year during 2001 through 2017.”

2. Cancer is contagious

This is a myth. Cancer is not contagious. Someone with cancer cannot spread it to others.

However, some sexually transmitted diseases, including human papillomavirus (HPV) and hepatitis B and C, can cause cancers in the cervix and the liver. In these cases, an infectious agent causes the cancer, but the cancer itself is not contagious.

As an interesting aside, scientists have documented that cancers in some animals, including Tasmanian devils and dogs, can cause fatal transmissible cancers: devil facial tumor disease and canine transmissible venereal tumor, respectively.

3. Cell phones cause cancer

To date, there is no evidence that cell phones cause cancer. One of the reasons this myth developed is that these devices emit radiofrequency radiation (radio waves), a form of non-ionizing radiation. The body absorbs this radiation.

Scientists know that exposure to ionizing radiation, for instance, X-rays, increases the risk of cancer. However, radiofrequency radiation is non-ionizing radiation, which does not increase cancer risk. The National Cancer Institute writes:

“[A]lthough many studies have examined the potential health effects of non-ionizing radiation from radar, microwave ovens, cell phones, and other sources, there is currently no consistent evidence that non-ionizing radiation increases cancer risk in humans.”

4. Power lines cause cancer

This is also a myth. The extremely low frequency (ELF) magnetic fields produced by power lines are non-ionizing and, therefore, do not cause cancer.

The American Cancer Society writes:

“Several large studies have looked at the possible effects of ELF magnetic fields on cancer in rats and mice. These studies expose the animals to magnetic fields much stronger than what people are normally exposed to at home […]. Most of these studies have found no increase in the risk of any type of cancer. In fact, the risk of some types of cancer was actually lower in the animals exposed to the ELF radiation.”

However, the American Cancer Society also explains that some studies have found a slight increase in leukemia risk for children who live close to power lines. However, the reasons for this remain unclear.

Medical News Today spoke with Dr. Joel Newman, a consultant hematologist and specialty lead for pathology at East Sussex Healthcare Trust in the U.K. He puts the risk into perspective:

“We don’t have any real evidence that cell phones or power lines cause cancer, and there are many other things that we do daily that put us at a much greater risk than these ever could, including smoking and alcohol consumption.”

5. Artificial sweeteners cause cancer

To date, there is no good evidence that artificial sweeteners increase the risk of developing cancer.

The National Cancer Institute explains why this myth may have arisen:

“Questions about artificial sweeteners and cancer arose when early studies showed that cyclamate in combination with saccharin caused bladder cancer in laboratory animals.”

However, they explain that further studies “have not provided clear evidence of an association with cancer in humans. Similarly, studies of other [Food and Drug Administration (FDA)]-approved sweeteners have not demonstrated clear evidence of an association with cancer in humans.”

Similarly, a study investigating aspartame and cancer, which included data from more than half a million participants, found no links between “aspartame consumption and lymphoma, leukemia, or brain cancer.”

6. Cancer surgery causes cancer to spread

This is only a partial myth. It is true that cancer surgery can cause the cancer to spread, but this is rare. As the American Cancer Society explains:

“Advances in equipment used during surgery and more detailed imaging tests have helped make this risk very low.”

A related myth indicates that a tumor will grow faster or spread to other parts of the body when exposed to the air. This is untrue.

7. Herbal medicines can cure cancer

There is no evidence that any herbal medicines can cure or treat cancer.

However, some people find certain alternative therapies, such as acupuncture, meditation, and yoga, help with the psychological stress associated with cancer and some of the side effects of cancer treatment.

As the National Cancer points out, just because something is “natural” does not mean it is safe. In some circumstances, herbal supplements can harm a person’s health; they provide a couple of examples:

“[S]ome studies have shown that kava kava, a herb that some people use to help with stress and anxiety, may cause liver damage. And St. John’s wort, which some people use for depression, may cause certain cancer drugs not to work as well as they should.”

It is important that people with cancer speak with a doctor about supplements and vitamins before taking them.

8. Cancer runs in families

Although some cancers are passed on genetically through families, they are the minority of cases: an estimated 3–10% of cancers result from mutations inherited from parents.

Because people are more likely to develop cancer as they age, and people today live longer lives, it is not uncommon for people to have some relatives who develop cancer. This might help explain why this myth persists.

Most cases of cancer are due to a buildup of mutations in genes that accumulate over time. As the American Cancer Society explains:

“Some types of cancer run in certain families, but most cancers are not clearly linked to the genes we inherit from our parents. Gene changes that start in a single cell over the course of a person’s life cause most cancers.”

9. Cancer always comes back

To address this question, MNT spoke with Dr. Collin Vu, a medical oncologist and hematologist at MemorialCare Cancer Institute at Orange Coast Medical Center in Fountain Valley, CA. He said:

“Fortunately for all of us, this statement is a myth and entirely not true. The current therapies for cancers are improving to the point where the cure of cancer — that is, treatments that will kill cancer completely — are improving continuously.”

However, he explains that the subject is complicated because “different cancer types have a markedly different ability to be cured, and different cancer types also have different time frames for which a cancer may typically recur. [This] makes it very difficult for patients to know when they may be truly ‘cured’ or when they still have a high risk of cancer recurrence.”

Dr. Vu has great hopes for the future of cancer treatment; he told MNT:

“In the future, with current scientific progress in better treatments for cancer, and improved population awareness of cancer risks and diagnosis, the statement that ‘cancer always comes back’ may become even more of a myth.”

10. There is no cure for cancer

Thankfully, this is also a myth. As medical science delves deeper into the mechanisms behind cancer, treatments steadily grow more effective.

According to Dr. Vu, some cancers, such as testicular and thyroid cancer, have a 60% cure rate. Dr. Vu defines the cure rate as “the population of cancer patients that has the same life expectancy as the general population.”

Breast, prostate, and bladder also have cure rates of around 50%. Dr. Vu concludes:

“As can be seen by the above data, some cancers can be eradicated, but, unfortunately, not all cancers can be cured completely. There is ongoing optimism that cure rates are increasing given the ongoing focus on screening and better treatments for cancer.”

MNT also spoke with Dr. Anton Bilchik, Ph.D., a surgical oncologist, professor of surgery, chief of gastrointestinal research, and chief of medicine at Saint John’s Cancer Institute at Providence Saint John’s Health Center in Santa Monica, CA. He also leads with a message of hope:

“It is imperative that patients who are diagnosed with cancer, even at an advanced stage, do not lose hope: there are many effective, novel therapies, as well as more effective surgical techniques. A good example is with the use of modern immunotherapy, up to 40% of patients with stage 4 melanoma are curable, and 50% of patients with stage 4 colon cancer metastatic to the liver can be cured with a combination of chemotherapy and surgery.”

In short: although the battle with cancer is ongoing, science is making significant headway.

by -
0 648

In laboratory studies, the active component of honeybee venom rapidly killed two types of breast cancer cells that are particularly difficult to treat. Crucially, the toxin left healthy cells unharmed.

For thousands of years, humans have used honey, propolis, and venom from the European honeybee Apis mellifera as medicines.

More recently, scientists have discovered that honeybee venom and its active component, melittin, are toxic to a wide range of tumors — including melanoma, lung, ovarian, and pancreatic cancers — in laboratory tests.

Melittin is the molecule that creates the painful sensation of a bee’s sting. Scientists do not fully understand how it kills cancer cells, however.

For the first time, researchers have investigated the effect of melittin and honeybee venom on a range of breast cancers, including two of the most aggressive and hard-to-treat types.

Breast cancer is the most common cancer in women. The two aggressive types, known as triple-negative breast cancer and HER2-enriched breast cancer, are associated with the poorest outcomes. They tend to develop resistance to existing treatments.

Scientists at the Harry Perkins Institute of Medical Research in Perth, Australia, and the University of Western Australia, also in Perth, found that melittin and honeybee venom rapidly kill these cancer types, with negligible effects on normal cells.

“The venom was extremely potent,” says Dr. Ciara Duffy, who led the research. “We found that melittin can completely destroy cancer cell membranes within 60 minutes.”

The study also showed that venom from bumblebees, which contains no melittin, did not kill the cancer cells — even at high concentrations.

The scientists report their work in the journal npj Precision Oncology.

Blocking messages

Melittin can kill cells in under 1 hour by punching holes in their outer membrane. However, within 20 minutes of administration, it also disrupts the passing of chemical messages that the cells need to grow and divide.

“We looked at how honeybee venom and melittin affect the cancer signaling pathways, the chemical messages that are fundamental for cancer cell growth and reproduction, and we found that very quickly these signaling pathways were shut down,” says Dr. Duffy.

The scientists discovered that melittin does this by preventing the activation of receptors for growth factors in the cells’ membrane. One of the reasons that HER2-enriched cancer cells and some triple-negative breast cancers grow uncontrollably is that they have large numbers of these receptors.

By preventing these growth signals from getting through, melittin halts the cells’ proliferation.

Prof. Peter Klinken, who was not involved in the research, is the chief scientist of Western Australia. He welcomes the findings, saying, “This is an incredibly exciting observation that melittin, a major component of honeybee venom, can suppress the growth of deadly breast cancer cells, particularly triple-negative breast cancer.”

He adds:

“Significantly, this study demonstrates how melittin interferes with signaling pathways within breast cancer cells to reduce cell replication. It provides another wonderful example of where compounds in nature can be used to treat human diseases.”

Combination therapy

Because melittin creates holes in cell membranes, it may also allow existing chemotherapy drugs to penetrate and kill cancer cells.

To test this possibility, the researchers treated a mouse model of triple-negative breast cancer with a combination of melittin and a drug called docetaxel. This proved more effective at shrinking the tumors than either docetaxel or melittin alone.

Doctors could potentially use this strategy to increase the efficacy or reduce the dosage of chemotherapy drugs, thereby reducing harmful side effects.

The study authors note that honeybee venom is relatively cheap and easily obtainable, making it a good option for cancer treatment in countries with poorly resourced health services.

They write:

“Honeybee venom is available globally and offers cost effective and easily accessible treatment options in remote or less developed regions. Further research will be required to assess whether the venom of some genotypes of bees has more potent or specific anticancer activities, which could then be exploited.”

This line of research is in its infancy, with researchers yet to perform clinical trials in humans to assess the safety and efficacy of melittin for treating breast cancer.

Although this particular study found no evidence of harm to noncancerous cells, other studies suggest otherwise. Therefore, healthcare professionals may need to carefully target melittin to tumors to prevent collateral damage to healthy tissue.

by -
0 523

Thanks to advanced medical treatments, women diagnosed with breast cancer today will likely survive the disease. However, some treatment options put these women at greater risk for a number of other health problems.

A new study out of Brazil shows that postmenopausal women with breast cancer are at greater risk for developing heart disease. Results are published online in Menopause, the journal of The North American Menopause Society (NAMS).

Cardiovascular disease remains the main cause of death in postmenopausal women, and women treated for breast cancer are at greater risk of developing heart disease than those not diagnosed with breast cancer. These cardiovascular effects may occur more than five years after radiation exposure, with the risk persisting for up to 30 years.

The goal of the new study was to compare and evaluate risk factors for cardiovascular disease in postmenopausal women who are survivors of breast cancer and women without breast cancer. The researchers found that postmenopausal women who are survivors of breast cancer showed a markedly stronger association with metabolic syndrome, diabetes, atherosclerosis, hypertriglyceridemia, and abdominal obesity, which are major risk factors for cardiovascular disease. The risk of cardiovascular mortality similarly increased to match death rates from the cancer itself.

Findings were published in the article “High risk for cardiovascular disease in postmenopausal breast cancer survivors.”

“Heart disease appears more commonly in women treated for breast cancer because of the toxicities of chemotherapy, radiation therapy, and use of aromatase inhibitors, which lower estrogen. Heart-healthy lifestyle modifications will decrease both the risk of recurrent breast cancer and the risk of developing heart disease,” says Dr. JoAnn Pinkerton, NAMS executive director. “Women should schedule a cardiology consultation when breast cancer is diagnosed and continue with ongoing follow-up after cancer treatments are completed.”

by -
0 631

A study in mice has found that scientists can switch off a gene responsible for an aggressive form of breast cancer. Silencing the gene not only shrinks tumors but also prevents their spread around the body.

Around one in eight females in the United States will develop breast cancer, according to the American Cancer Society.

In 2019, doctors diagnosed an estimated 268,600 new cases of invasive breast cancer in females in the U.S., while around 41,760 individuals died from the disease.

Up to a fifth of breast cancers are a more aggressive form known as triple-negative breast cancer that is difficult to treat.

Unlike the majority of breast cancers, estrogen and progesterone do not fuel the growth of triple-negative tumors, so drugs, such as tamoxifen, that block these hormones are ineffective.

A molecule that switches off a particular gene in triple-negative tumors could be a promising alternative treatment, according to research at Tulane University School of Medicine in New Orleans, LA.

The scientists report their discovery in the Nature journal Scientific Reports.

The effect of gene silencing

The research combined in vitro studies of cells growing in dishes with in vivo studies involving mice.

The team began by working with cultures of a triple-negative cancer cell line that originally came from a patient treated in 1973 at the M. D. Anderson Cancer Center in Houston, TX.

The researchers compared the effects of switching off two known breast cancer genes, one called Rab27a and the other TRAF3IP2.

To deactivate or “silence” the genes, they targeted them with molecules of short hairpin RNAs called lentiviral-TRAF3IP2-shRNA. These are strands of RNA twisted back on themselves like a hairpin that prevent a specific gene from being read or “transcribed” to make a protein.

The researchers discovered that switching off TRAF3IP2 had a more disruptive effect on cancer-associated metabolic pathways in the cells than switching off Rab27a.

They confirmed this by switching off the genes individually in a mouse model of breast cancer.

Switching off Rab27a did slow down tumor growth in the mice, but a very small number of cancer cells spread, or “micrometastasized.”

When the researchers switched off TRAF3IP2, however, this not only suppressed new tumor growth but also prevented metastasis for up to 1 year. Better still, the treatment shrank existing tumors until they were undetectable.

“This exciting discovery has revealed that TRAF3IP2 can play a role as a novel therapeutic target in breast cancer treatment,” says Dr. Reza Izadpanah, assistant professor of medicine at Tulane University School of Medicine, who led the research.

Future studies ‘to further validate’ findings

The scientists are now seeking approval from the Food and Drug Administration (FDA) to start clinical trials as soon as possible.

They write that, first, they will need to confirm their results by transplanting breast cancer cells from human patients into mice, in a process known as ‘xenotransplantation.’

“A limitation of the present study is that we used a single breast cancer cell line to investigate potential roles of silencing Rab27a and TRAF3IP2 on tumor growth. Our future studies will involve the use of patient-derived xenotransplants to further validate these fundamental first in vivo and in vitro results.”

– Eckhard U. Alt et al.

Silencing TRAF3IP2 may turn out to be an effective treatment in several cancers and even heart failure.

The gene is known to activate various cellular pathways that promote inflammation, which plays an important role not only in cancer but also in heart failure.

In their breast cancer research, the team at Tulane School of Medicine collaborated with Dr. Chandrasekar Bysani at the University of Missouri School of Medicine in Columbia, who identified the part played by TRAF3IP2 in promoting inflammation in heart failure.

Dr. Bysani also took part in recent research that found that switching off TRAF3IP2 could be an effective strategy for treating glioblastoma, a malignant type of brain cancer.

by -
0 588

Two recent but separate studies have demonstrated how bitter melon and turmeric could be used to prevent, treat and reduce the progression of cancers.

Commonly called bitter melon, bitter gourd, African cucumber or balsam pear, Momordica charantia belongs to the plant family Cucurbitaceae. In Nigeria, bitter melon is called ndakdi in Dera; dagdaggi in Fula-Fulfulde; hashinashiap in Goemai; daddagu in Hausa; iliahia in Igala; akban ndene in Igbo (Ibuzo in Delta State); dagdagoo in Kanuri; akara aj, ejinrin nla, ejinrin weeri, ejirin-weewe or igbole aja in Yoruba.

Turmeric is a spice that comes from the root of Curcuma longa, a member of the ginger family, Zingaberaceae. In traditional medicine, turmeric has been used for its medicinal properties for various indications and through different routes of administration, including topically, orally, and by inhalation.

In Nigeria, it is called atale pupa in Yoruba; gangamau in Hausa; nwandumo in Ebonyi; ohu boboch in Enugu (Nkanu East); gigir in Tiv; magina in Kaduna; turi in Niger State; onjonigho in Cross River (Meo tribe).

Turmeric, also known as curcuma, produces a root that is used to produce the vibrant yellow spice used as a culinary spice so often used in curry dishes. Though native to India and parts of Asia, and is a relative of cardamom and ginger, turmeric has been domesticated in Nigeria. In Asia, turmeric is used to treat many health conditions and it has anti-inflammatory, antioxidant, and perhaps even anticancer properties.

Meanwhile, Prof. Ratna Ray from Saint Louis University in Missouri, United States (U.S.), and her colleagues, in a recent study on bitter melon, made an intriguing find. In experiments using mouse models, bitter melon extract appeared to be effective in preventing cancer tumours from growing and spreading.

The researchers report their findings in a study paper that now appears in the journal Cell Communication and Signaling. Ray grew up in India, so she was familiar not just with the culinary qualities of bitter melon, but also with its alleged medicinal properties.

This made her curious as to whether or not the plant also harbored properties that would make it an effective aid to anticancer treatments. She and her colleagues decided to put this to the test in a preliminary study by using bitter melon extract on various types of cancer cells — including breast, prostate, and head and neck cancer cells.

Laboratory tests showed that the extract stopped those cells from replicating, suggesting that it might be effective in preventing the spread of cancer. In further experiments using mouse models, the researchers found that the plant extract was able to reduce the incidence of tongue cancer.

So, in their new study, Prof. Ray and team tried to find out what might give bitter melon compounds an edge against cancer cells. This time, they used mouse models to study the mechanism through which bitter melon extract interacted with tumors of cancer of the mouth and tongue.

They saw that the extract interacted with molecules that allow glucose (simple sugar) and fat to travel around the body, in some cases “feeding” cancer cells and allowing them to thrive.

By interfering with those pathways, the bitter melon extract essentially stopped cancer tumors from growing, and it even led to the death of some of the cancer cells. Ray said: “All animal model studies that we’ve conducted are giving us similar results, an approximately 50 per cent reduction in tumor growth.”

Ray and colleagues explained that it remains unclear whether or not bitter melon would have the same effect in humans, but Prof., going forward, this is what they are aiming to find out.

“Our next step is to conduct a pilot study in [people with cancer] to see if bitter melon has clinical benefits and is a promising additional therapy to current treatments,” she noted.

Ray seemed convinced that the plant is, if nothing else, at least a positive contributor to personal health.“Some people take an apple a day, and I’d eat a bitter melon a day. I enjoy the taste,” she said.“Natural products play a critical role in the discovery and development of numerous drugs for the treatment of various types of deadly diseases, including cancer. Therefore, the use of natural products as preventive medicine is becoming increasingly important.”

Meanwhile, a recent literature review investigated whether turmeric may be useful for treating cancer. The authors concluded that it might be but noted that there are many challenges to overcome before it makes it to the clinic. The chemical in turmeric that most interests medical researchers is a polyphenol called diferuloylmethane, which is more commonly called curcumin. Most of the research into turmeric’s potential powers has focused on this chemical.

Over the years, researchers have pitted curcumin against a number of symptoms and conditions, including inflammation, metabolic syndrome, arthritis, liver disease, obesity, and neurodegenerative diseases, with varying levels of success.
Above all, though, scientists have focused on cancer. According to the authors of the recent review, of the 12,595 papers that researchers published on curcumin between 1924 and 2018, 37 per cent focus on cancer.

In the current review, which features in the journal Nutrients, the authors mainly focused on cell signaling pathways that play a role in cancer’s growth and development and how turmeric might influence them. Treatment for cancer has improved vastly over recent decades, but there is still a long path to tread before we can beat cancer. As the authors note, “the search for innovative and more effective drugs” is still vital work.

In their review, the scientists paid particular attention to research involving breast cancer, lung cancer, cancers of the blood, and cancers of the digestive system. The authors concluded: “Curcumin represents a promising candidate as an effective anticancer drug to be used alone or in combination with other drugs.”

According to the review, curcumin can influence a wide range of molecules that play a role in cancer, including transcription factors, which are vital for Deoxy ribonucleic Acid (DNA)/genetic material replication; growth factors; cytokines, which are important for cell signaling; and apoptotic proteins, which help control cell death.

Alongside the discussions surrounding curcumin’s molecular influence over cancer pathways, the authors also addressed the possible issues with using curcumin as a drug. For instance, they explain that if a person takes curcumin orally — in a turmeric latte, for example — the body rapidly breaks it down into metabolites. As a result, any active ingredients are unlikely to reach the site of a tumour.

With this in mind, some researchers are trying to design ways of delivering curcumin into the body and protecting it from undergoing metabolisation. For instance, researchers who encapsulated the chemical within a protein nanoparticle noted promising results in the laboratory and in rats.

Although scientists have published a great many papers on curcumin and cancer, there is a need for more work. Many of the studies in the current review are in vitro studies, which means that the researchers conducted them in laboratories using cells or tissues. Although this type of research is vital for understanding which interventions may or may not influence cancer, not all in vitro studies translate to humans.

Relatively few studies have tested turmeric’s or curcumin’s anticancer properties in humans, and the human studies that have taken place have been small-scale. However, aside from the difficulties and limited data, curcumin still has potential as an anticancer treatment.

Scientists are continuing to work on the problem. For instance, the authors mention two clinical trials that are underway, both of which aim to “evaluate the therapeutic effect of curcumin on the development of primary and metastatic breast cancer, as well as to estimate the risk of adverse events.”

They also refer to other ongoing studies in humans that are evaluating curcumin as a treatment for prostate cancer, cervical cancer, and lung nodules, among other diseases. The authors believe that curcumin belongs to “the most promising group of bioactive natural compounds, especially in the treatment of several cancer types.”

However, their praise for curcumin as an anticancer hero is tempered by the realities that their review has unearthed, and they end their paper on a low note: “Curcumin is not immune from side effects, such as nausea, diarrhea, headache, and yellow stool. Moreover, it showed poor bioavailability due to the fact of low absorption, rapid metabolism, and systemic elimination that limit its efficacy in diseases treatment. Further studies and clinical trials in humans are needed to validate curcumin as an effective anticancer agent.”

Meanwhile, an earlier study published in journal Current Pharmacology Reports established that besides diabetes, bitter melon is effective in treating other chronic diseases such as cancer and Human Immuno-deficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS).

The study is titled “Bitter Melon as a Therapy for Diabetes, Inflammation, and Cancer: a Panacea?” The researchers noted: “Over the last few decades, multiple well-structured scientific studies have been performed to study the effects of bitter melon in various diseases. Some of the properties for which bitter melon has been studied include: antioxidant, anti-diabetic, anticancer, anti-inflammatory, antibacterial, antifungal, antiviral, anti-HIV, anthelmintic, hypotensive, anti-obesity, immuno-modulatory, anti-hyperlipidemic, hepato-protective, and neuro-protective activities. This review attempts to summarize the various literature findings regarding medicinal properties of bitter melon. With such strong scientific support on so many medicinal claims, bitter melon comes close to being considered a panacea.”

According to Food as Medicine: Functional Food Plants of Africa published 2017 by CRC Press, “…Dietary use of bitter melon or its juice decreases blood glucose levels, increases High Density Lipo-protein (HDL)/good cholesterol, and decreases triglyceride levels, thus exhibiting antiatherogenic qualities. Extract of bitter melon in supplement form has been widely used as a traditional medicine for diabetic patients.

When administered alone, it has a modest hypoglycemic effect at doses of at least 2000 mg/day. This botanical supplement enhances the cellular uptake of glucose and promotes insulin release, potentiating its effect, and in animal studies has been shown to increase the number of insulin-producing beta cells in diabetic animals. Bitter melon has also been found to reduce adiposity and oxidative stress in addition to reducing blood triglycerides and Low Density Lipo-proteins (LDL)/bad cholesterol.”

by -
0 1631

Tap water may be the cause of one in 20 cases of bladder cancer in Europe each year, a major study suggests. Researchers have linked drinking, showering and bathing in the water to more than 6,500 cases of the disease in 26 countries across the continent.

They estimate 1,356 bladder cancer diagnoses in Britain since 2005 were caused by contaminated water, making up a fifth of all cases in the European Union (EU).

Long-term exposure to a group of chemicals called trihalomethanes (THMs) is thought to be the cause. The chemicals, shown to be carcinogenic in animal studies, are formed as an unintended byproduct when water is disinfected with chlorine at supply plants.

As well as being drunk, steam given off in the shower can allow tap water to seep into people’s pores, and so too can prolonged periods in the bath. Earlier research has found an association between THMs and bladder cancer, but this is the first to estimate the scale of the problem. Some 10,000 people are diagnosed with bladder cancer each year in the United Kingdom (UK), making it the tenth most common form of the disease.

The latest study estimates nine per cent of them are caused by exposure to water contaminated with THMs.The findings are published in the journal Environmental Health Perspectives. Scientists from the Barcelona Institute for Global Health (ISGlobal) set out to analyse the presence of the chemicals in drinking water in all 28 EU states between 2005 and 2018.

They did this by sending questionnaires to bodies responsible for the national water quality. Data was obtained for 26 countries – all except Bulgaria and Romania. The scientists probed levels of THMs in water at the tap, in the distribution network and at water treatment plants.

To make estimates as accurate as possible, the researchers also used other sources including open data online, reports and scientific literature. The findings revealed considerable differences between countries. Average THM levels were above legal levels in nine countries – Britain (24.2ug/l) , Spain, Portugal, Poland, Cyprus, Estonia, Hungary, Ireland and Italy.

The European Union has said the maximum limit is 11.7 micrograms per litre (ug/L). The European Union has said the maximum limit of THMs in water should be 11.7 micrograms per litre (ug/L). Researchers estimated the number of attributable bladder cancer cases using incidence rates and levels of THMs.

Analysis suggested Cyprus had highest percentage, with a quarter of diagnoses linked to the chemicals. Joint second-wort were Ireland and Malta, where one in six bladder cancer patients (17 per cent) are thought to have developed it from exposure to tap water.

Spain (11 per cent) and Greece (10 per cent) were not much better. At the opposite extreme was Denmark, where less than 0.1 per cent of cases were caused by THM water contamination. In Holland it was just 0.1 per cent of cases and Germany 0.2 per cent. THMs could be blamed for 0.4 per cent of cases in Austria and Lithuania. In total, the researchers estimated that 6,561 bladder cancer cases per year are attributable to THM exposure in the European Union.

The study authors say if the 13 countries with the highest averages were to reduce their THM levels to the EU average, 2,868 annual bladder cancer cases could be avoided.

Chloroform is the most infamous type of THM, which the World Health Organisation (WHO) describes as ‘probably carcinogenic to humans’.Co-study author Manolis Kogevinas, a researcher from ISGlobal, said: “Over the past 20 years, major efforts have been made to reduce trihalomethanes levels in several countries of the European Union, including Spain.

“However, the current levels in certain countries could still lead to considerable bladder cancer burden, which could be prevented by optimising water treatment, disinfection and distribution practices and other measures.”

A spokesperson for Britain’s Department for Environment, Food and Rural Affairs said: “This Government takes the safety of our drinking water extremely seriously, and have a robust monitoring regime in place which tests for a wide range of chemicals, including trihalomethanes, to ensure the public can have absolute faith in the water coming from their taps.

“The latest figures from 2018 found only four samples out of 11,900 exceeded the legal limits, and firm action was taken in each of these four cases.”

A study in September last year discovered 22 carcinogenic substances in water across the United States (U.S.).Despite the fact that most of the water systems they tested were within federal limits on each of these toxins, the scientists estimated that their cumulative effects could be dire over the course of Americans’ lifetimes.

Exposure to arsenic, products of disinfectant chemicals and traces of radioactive chemicals like uranium and radium had the most substantial effects on cancer risks. Over 1.7 million new cases of cancer are diagnosed in the US each year. In the same time period, over 600,000 people die of the disease.

Better prevention strategies, earlier detection and better treatments – like the immunotherapies that are revolutionizing the disease’s future – have driven cancer mortality down dramatically. Yet the disease’s elimination is no where in sight. In part, this is because its roots are many, and difficult to control.

Rather than being triggered by any one thing, genetics, what you eat, where you live, how you eat and, of course, the water you drink all play roles in raising or lowering cancer risks.

Some chemicals, like arsenic are nearly impossible to keep out of water in certain places. For example, in some areas of Illinois, the soil is rich in arsenic, a toxic, carcinogenic heavy metal, linked to liver and bladder cancers.

Arsenic seeps into the ground water, and winds up in our bodies. It also leaks into the water supply from many types of manufacturing plants.US water systems treat drinking water with chlorine – a non-carcinogenic cleaning chemical – in an attempt to reduce or eliminate the metal.

by -
0 630

Previous research has suggested that there is a link between depression and tea drinking. Now, a new study is investigating this relationship further.

Depression is common among older adults, with 7% of those over the age of 60 years reporting “major depressive disorder.”

Accordingly, research is underway to identify possible causes, which include genetic predisposition, socioeconomic status, and relationships with family, living partners, and the community at large.

A study by researchers from the National University of Singapore (NUS) and Fudan University in Shanghai raises another possibility. It finds a statistically significant link between regular tea drinking and lower levels of depression in seniors.

While the researchers have not yet established a causal relationship between tea and mental health, their findings — which appear in BMC Geriatrics — show a strong association.

Reading the tea leaves

Tea is popular among older adults, and various researchers have recently been investigating the potential beneficial effects of the beverage.

A separate study from the NUS that appeared in Aging last June, for example, found that tea may have properties that help brain areas maintain healthy cognitive function.

“Our study offers the first evidence of the positive contribution of tea drinking to brain structure and suggests a protective effect on age-related decline in brain organization.”

Junhua Li, lead author

That earlier paper also cites research showing that tea and its ingredients — catechin, L-theanine, and caffeine — can produce positive effects on mood, cognitive ability, cardiovascular health, cancer prevention, and mortality.

However, defining the exact role of tea in preventing depression is difficult, especially due to the social context in which people often consume it. Particularly in countries such as China, social interaction may itself account for some or even all of the drink’s benefits.

Feng Qiushi and Shen Ke led the new study, which tracks this covariate and others, including gender, education, and residence, as well as marital and pension status.

The team also factored in lifestyle habits and health details, including smoking, drinking alcohol, daily activities, level of cognitive function, and degree of social engagement.

In addition, the authors write, “The study has major methodological strength,” citing a few of its attributes.

Firstly, they note, it could more accurately track an individual’s tea-drinking history because “instead of examining tea-drinking habit [only] at the time of survey or in the preceding month/year, we combined the information on frequency and consistency of tea consumption at age 60 and at the time of assessment.”

Once the researchers had classified each person as one of four types of tea drinker according to how often they drank the beverage, they concluded:

“[O]nly consistent daily drinkers, those who had drunk tea almost every day since age 60, could significantly benefit in mental health.”

13,000 study participants

The researchers analyzed the data of 13,000 individuals who took part in the Chinese Longitudinal Healthy Longevity Survey (CLHLS) between 2005 and 2014.

They discovered a virtually universal link between tea drinking and lower reports of depression.

Other factors seemed to reduce depression as well, including living in an urban setting and being educated, married, financially comfortable, in better health, and socially engaged.

The data also suggested that the benefits of tea drinking are strongest for males aged 65 to 79 years. Feng Qiushi suggests an explanation: “It is likely that the benefit of tea drinking is more evident for the early stage of health deterioration. More studies are surely needed in regard to this issue.”

Looking at the connection the other way around, tea drinkers appeared to share certain characteristics.

Higher proportions of tea drinkers were older, male, and urban residents. In addition, they were more likely to be educated, married, and receiving pensions.

Tea drinkers also exhibited higher cognitive and physical function and were more socially involved. On the other hand, they were also more likely to drink alcohol and smoke.

Qiushi previously published the results of the effect of tea drinking on a different population, Singaporeans, finding a similar link to lower rates of depression. The new study, while more detailed, supports this earlier work.

Currently exploring new CLHLS data regarding tea drinking, Qiushi wishes to understand more about what tea can do, saying, “This new round of data collection has distinguished different types of tea, such as green tea, black tea, and oolong tea so that we could see which type of tea really works for alleviating depressive symptoms.”

by -
0 1208

A blemish is the term for any mark on the skin. There are many different types of blemish.

Most blemishes are harmless, but some people may wish to treat them for cosmetic reasons.

Certain blemishes may indicate an underlying condition, such as skin cancer, which requires prompt medical treatment.

In this article, we outline the different types of blemish that people may have and the treatment options available in each case.

Types

There are many different types of skin blemish. Some examples include those below.

Acne

Acne is a skin condition that occurs as a result of the skin producing too much oil. Different factors can cause excess oil production, including:

  • overactive oil glands
  • hormonal changes during puberty, menstruation, or the menopause
  • stress, anxiety, or depression, which can also affect hormones

There are several different types of acne, which vary in their appearance. Some examples include:

Blackheads

Blackheads are small, dark spots on the surface of the skin. They resemble trapped dirt but actually consist of oil that has become stuck inside the pore. When this oil reacts with air, it becomes black.

Whiteheads

Whiteheads are small, round blemishes that are white or skin-colored. They develop as a result of oil and dead skin cells blocking the pores.

Papules

Papules are small, hard, red bumps on the skin. These develop when excess oil, bacteria, and dead skin cells travel deeper into the skin, causing inflammation.

When lots of papules cluster together, this can give the skin a rough, sandpaper-like texture.

Pustules

Pustules are raised, red spots that contain yellow or white pus. They occur when oil, bacteria, and dead skin cells collect under the skin, causing infection.

Nodules

Nodules are large skin blemishes that develop when a pore becomes clogged. Oils mix with dead skin cells and bacteria that then become trapped deep in the skin. The excess oil and bacteria lead to infection and inflammation inside the skin.

This type of skin blemish can cause acne scarring.

Acne cysts

A break in the lining of a pore can cause oil and bacteria to spread to the surrounding skin. An acne cyst is a membrane that has formed around the infected area.

Cysts appear as large, swollen, red blemishes. They may be very painful to the touch.

Like nodules, cysts can cause permanent acne scarring.

Hyperpigmentation

Hyperpigmentation is a type of blemish that appears darker than other areas of skin. It is common and usually harmless.

Hyperpigmentation can occur as a result of genetic factors, sun damage, or acne scarring.

Freckles are a type of hyperpigmentation that a person can inherit the tendency to develop. They are small, flat spots that may be red, brown, tan, or black. They can appear anywhere on the body.

Sunspots or “age spots” are another type of hyperpigmentation. These small spots or patches can develop on areas of the skin that get a lot of sun exposure.

Acne scarring can also cause dark spots to remain on the skin once the acne has cleared.

Melasma

Melasma is a type of hyperpigmentation that can develop during pregnancy or when a person takes birth control pills.

The hormonal changes that take place lead to an increase in melanin. Melanin is the pigment that gives skin its coloring. The overproduction of melanin can make the skin darker.

Ingrown hair

Sometimes, hairs can curl back on themselves or grow sideways into the skin, which can result in red, itchy bumps forming. Doctors refer to these skin blemishes as ingrown hairs.

Hair removal techniques, such as waxing, shaving, or plucking, can all cause ingrown hairs.

Birthmarks

Birthmarks are blemishes that appear on the skin of a newborn baby. They can appear either at birth or shortly afterward. Some birthmarks disappear over time, while others may be permanent.

Experts are still not sure what causes birthmarks to form. However, these skin blemishes can sometimes develop as a result of:

  • blood vessels not forming properly
  • skin pigment cells clumping together, creating moles or patches of darker skin
  • an overgrowth of skin that creates raised patches of thickened skin

A birthmark will look different than the skin surrounding it. These types of skin blemish can be any size and may vary greatly in appearance. They may be:

  • flat or raised
  • similar to a bruise or stain
  • any color, including pink, red, brown, or tan

Birthmarks are generally harmless, but some marks that appear on a baby’s skin can signal an underlying condition. It is best to have a dermatologist check any birthmarks just to be sure.

Some harmless birthmarks can also get larger quickly, which can be alarming. Talking with a dermatologist can help people know what to expect regarding birthmark growth.

Cold sores

Cold sores are painful, red, fluid-filled blisters that form on the lips or around the mouth. They occur as a result of infection with the herpes simplex virus.

Cold sores are highly contagious, so people should avoid intimate contact with others until the sores have healed to avoid passing the virus on.

Skin cancer

Some types of blemish can be a sign of skin cancer. Being aware of the signs to look out for can help people spot skin cancer early.

Some potential signs of skin cancer include:

  • a new mole or mark that grows quickly
  • a mole or mark that bleeds or itches
  • a blemish that changes in shape, size, or color
  • a mole that is asymmetrical or has rough, irregular edges
  • a mole that is larger than 6 millimeters

A person should see a doctor if they develop a new or unusual skin blemish that has any of the above characteristics.

Treatments

Although many types of skin blemish do not require treatment, some people may wish to treat them for cosmetic reasons. The type of skin blemish will determine the treatment options.

Acne treatment

People may be able to treat acne blemishes with topical creams, such as benzoyl peroxide.

These products can help dry out the skin and get rid of acne-causing bacteria.

Washing the face twice daily with a cleanser containing benzoyl peroxide or salicylic acid can help treat certain types of acne. In addition, medications called retinoids may help unclog the pores.

Acne treatments can take time to have a noticeable effect. People may need to wait 6–8 weeks for them to work.

For persistent acne, a dermatologist may suggest a topical or oral prescription medication. Some prescription treatments for acne and hyperpigmentation can cause side effects.

People should discuss any potential side effects with their dermatologist before starting treatment.

Some people may also find that certain dietary and lifestyle changes can help reduce stress levels and balance hormones.

Hyperpigmentation and melasma treatment

The following treatments may help reduce hyperpigmentation and melasma:

  • over-the-counter or prescription medicine containing hydroquinone, which works by lightening darker patches of skin
  • prescription cortisone or tretinoin cream
  • laser treatment

In some cases, melasma disappears after a woman has given birth or is no longer taking hormonal contraception.

Ingrown hair treatment

Some tips for preventing ingrown hairs include:

  • shaving only in the direction of hair growth
  • using a shaving gel
  • using only clean, sharp razors

For existing ingrown hairs, an exfoliating scrub can help release trapped hairs from under the skin.

Birthmark treatment

If people want to treat a birthmark, they may consider the following options:

  • laser therapy
  • medications, such as propranolol, timolol, or corticosteroids, which can shrink certain birthmarks
  • surgery to remove a birthmark that may be harmful

People may also use makeup to cover any blemishes or discolored skin that they wish to disguise.

Cold sore treatment

Cold sores tend to clear up on their own within 2 weeks. A dermatologist may also prescribe an oral or topical antiviral medicine to treat cold sores.

Skin cancer treatment

Skin cancer is very treatable if a person begins treatment in the early stages of the disease. The treatment that a person receives will depend on the type of skin cancer. Some possible treatment options include:

  • surgical removal of cancerous cells
  • topical medication to kill cancerous cells
  • radiation therapy

When to see a dermatologist

Some people may choose to see a dermatologist if they wish to treat a blemish for cosmetic reasons or if the blemish is causing them psychological distress.

A person should see their dermatologist immediately if they have a skin blemish that takes on any of the following characteristics:

  • grows quickly
  • changes in size, shape, or color
  • bleeds or itches

These could be signs of skin cancer or another serious skin condition that requires immediate treatment.

Summary

A blemish is any type of mark on the skin. Most blemishes are harmless, but people may choose to treat them for cosmetic reasons.

Certain types of skin blemish may be more serious. People should see a doctor or dermatologist if they develop a blemish that has any of the characteristic signs of skin cancer. This type of cancer is highly treatable if a person begins treatment during the early stages of the disease.

People should see a doctor or dermatologist if they have any concerns about a skin blemish or skin condition. These healthcare professionals can diagnose the condition and then recommend appropriate treatments.

123...4Next Page 1 of 4
© Copyright 2015 - 9jahealth. A Cyborg Business